PT716611E - Metodo para reduzir a lesao do miocardio durante um enfarte do miocardio agudo - Google Patents
Metodo para reduzir a lesao do miocardio durante um enfarte do miocardio agudoInfo
- Publication number
- PT716611E PT716611E PT94929047T PT94929047T PT716611E PT 716611 E PT716611 E PT 716611E PT 94929047 T PT94929047 T PT 94929047T PT 94929047 T PT94929047 T PT 94929047T PT 716611 E PT716611 E PT 716611E
- Authority
- PT
- Portugal
- Prior art keywords
- esterase inhibitor
- pct
- myocardial infarction
- acute myocardial
- acute
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Electrotherapy Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93202572 | 1993-09-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT716611E true PT716611E (pt) | 2002-06-28 |
Family
ID=8214075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94929047T PT716611E (pt) | 1993-09-01 | 1994-08-31 | Metodo para reduzir a lesao do miocardio durante um enfarte do miocardio agudo |
Country Status (10)
Country | Link |
---|---|
US (1) | US6090777A (pt) |
EP (1) | EP0716611B1 (pt) |
JP (2) | JP4077030B2 (pt) |
AT (1) | ATE212859T1 (pt) |
AU (1) | AU678064B2 (pt) |
DE (1) | DE69429816T2 (pt) |
DK (1) | DK0716611T3 (pt) |
ES (1) | ES2171465T3 (pt) |
PT (1) | PT716611E (pt) |
WO (1) | WO1995006479A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19829014A1 (de) * | 1998-06-30 | 2000-01-05 | Centeon Pharma Gmbh | Modifizierter C1-Esterase-Inhibitor zur Blockierung der Infektiosität von HIV |
US7008645B2 (en) * | 1998-07-14 | 2006-03-07 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Method of inhibiting restenosis using bisphosphonates |
CA2426115A1 (en) * | 2003-04-18 | 2004-10-18 | Victor Gurewich | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
US10517883B2 (en) * | 2003-06-27 | 2019-12-31 | Zuli Holdings Ltd. | Method of treating acute myocardial infarction |
US20060051407A1 (en) * | 2003-06-27 | 2006-03-09 | Yoram Richter | Method of treating ischemia-reperfusion injury |
US20070196367A1 (en) * | 2006-02-22 | 2007-08-23 | Valentin Dinu | Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system |
US20090010916A1 (en) * | 2006-06-22 | 2009-01-08 | Victor Gurewich | C-1 Inhibitor prevents non-specific plasminogen activation by a prourokinase mutant without impeding fibrin-specific fibrinolysis |
HUE026042T2 (en) | 2006-10-10 | 2016-05-30 | Regenesance B V | Complement inhibition for improved nerve regeneration |
CA2889170C (en) | 2012-10-25 | 2021-09-07 | True North Therapeutics, Inc. | Anti-complement c1s antibodies and uses thereof |
WO2014071206A1 (en) | 2012-11-02 | 2014-05-08 | True North Therapeutics, Inc. | Anti-complement c1s antibodies and uses thereof |
JP6289511B2 (ja) * | 2013-02-28 | 2018-03-07 | ツェー・エス・エル・ベーリング・ゲー・エム・ベー・ハー | 羊水塞栓の治療剤 |
KR102403299B1 (ko) * | 2013-03-08 | 2022-06-03 | 체에스엘 베링 게엠베하 | 원격 허혈-재관류 손상의 치료 및 예방 |
US9993427B2 (en) | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
WO2014145519A2 (en) | 2013-03-15 | 2014-09-18 | Viropharma Holdings Limited | C1-inh compositions and methods for the prevention and treatment of disorders associated with c1 esterase inhibitor deficency |
CN105339010A (zh) * | 2013-06-28 | 2016-02-17 | 德国杰特贝林生物制品有限公司 | 使用因子xii抑制剂和c1-抑制剂的联合疗法 |
AU2016246452B2 (en) | 2015-04-06 | 2022-03-10 | Bioverativ Usa Inc. | Humanized anti-C1s antibodies and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3228502A1 (de) * | 1982-07-30 | 1984-02-02 | Behringwerke Ag, 3550 Marburg | Verfahren zur herstellung des c1-inaktivators und seine verwendung |
FR2601034B1 (fr) * | 1986-07-03 | 1989-11-17 | Pasteur Institut | Inhibiteur de l'activite de la c1-esterase plasmatique (c1-inhibiteur) et d'autres enzymes proteolytiques du groupe des proteases a serine, son procede de preparation, acides nucleiques codant pour cet inhibiteur, methodes de detection d'affections correlees aux defauts dudit inhibiteur a l'aide d'anticorps ou de sondes nucleotidiques et medicaments contenant ledit inhibiteur de synthese |
EP0497833A1 (en) * | 1989-10-27 | 1992-08-12 | Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis | C1 inhibitor muteins and uses thereof |
WO1992022320A1 (en) * | 1991-06-14 | 1992-12-23 | Genentech, Inc. | C1 inhibitor variants and treating inflammatory response with c1 inhibitor |
-
1994
- 1994-08-31 US US08/604,933 patent/US6090777A/en not_active Expired - Lifetime
- 1994-08-31 PT PT94929047T patent/PT716611E/pt unknown
- 1994-08-31 AT AT94929047T patent/ATE212859T1/de active
- 1994-08-31 AU AU78239/94A patent/AU678064B2/en not_active Expired
- 1994-08-31 DE DE69429816T patent/DE69429816T2/de not_active Expired - Lifetime
- 1994-08-31 JP JP50804995A patent/JP4077030B2/ja not_active Expired - Lifetime
- 1994-08-31 ES ES94929047T patent/ES2171465T3/es not_active Expired - Lifetime
- 1994-08-31 DK DK94929047T patent/DK0716611T3/da active
- 1994-08-31 EP EP94929047A patent/EP0716611B1/en not_active Expired - Lifetime
- 1994-08-31 WO PCT/NL1994/000208 patent/WO1995006479A1/en active IP Right Grant
-
2007
- 2007-11-21 JP JP2007301371A patent/JP2008056705A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0716611B1 (en) | 2002-02-06 |
AU7823994A (en) | 1995-03-22 |
JPH09501946A (ja) | 1997-02-25 |
ES2171465T3 (es) | 2002-09-16 |
WO1995006479A1 (en) | 1995-03-09 |
DE69429816T2 (de) | 2002-09-19 |
AU678064B2 (en) | 1997-05-15 |
DE69429816D1 (de) | 2002-03-21 |
EP0716611A1 (en) | 1996-06-19 |
DK0716611T3 (da) | 2002-05-21 |
JP4077030B2 (ja) | 2008-04-16 |
US6090777A (en) | 2000-07-18 |
ATE212859T1 (de) | 2002-02-15 |
JP2008056705A (ja) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT716611E (pt) | Metodo para reduzir a lesao do miocardio durante um enfarte do miocardio agudo | |
NO952228L (no) | Anvendelse av lamotrigin ved behandling av neurologiske lesjoner relatert til traumatiske skader | |
MY129293A (en) | The use of mmp-13 selective inhibitors for the treatment of osteoarthristis and other mmp-mediated disorders | |
EP1007556A4 (en) | TROPONIN SUB-UNITS AND FRAGMENTS FOR USE AS INHIBITORS OF ANGIOGENESIS | |
MX9700237A (es) | Combinaciones inhibidoras de proteasa retroviral. | |
ZA88798B (en) | Dental anti-plaque and anti-caries agent | |
ES2136723T3 (es) | Utilizacion de n-aril-metilen-etilen-diamino-triacetatos, n-aril-metilen-imino-diacetatos o n,n'-diaril-metilen-etilen-diamino-acetatos contra el estres oxidante. | |
AU7321598A (en) | Use of cholinesterase inhibitors to treat disorders of attention | |
HUP0002755A2 (hu) | Eljárások szklerózis multiplexben szenvedő betegek kezelésére konszenzus interferonnal | |
DK0723444T3 (da) | Levobupivacain, som er egnet til behandling af kronisk smerte | |
PL309596A1 (en) | Application of anticonvulsant agents in treating parkinson disease and parkinsonian syndromes | |
DE69410254D1 (de) | Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente | |
DE69333639D1 (en) | Trypsininhibitoren | |
ATE152628T1 (de) | Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft | |
CO5570661A2 (es) | Combinaciones que comprenden inhibidores de cox-2 y aspirina | |
DK0876158T3 (da) | Ny medicinsk anvendelse af en ACE-inhibitor til behandling af mavesurhedssymptomer | |
CZ157795A3 (en) | Pharmaceutical preparations for treating prostatitis | |
CA2170739A1 (en) | Method to reduce myocardial injury during acute myocardial infarction | |
BG103859A (en) | The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions | |
ATE185144T1 (de) | Antimessenger oligonukleotide und urokinaserezeptor umkehrung des invasive phänotyps transformieter menschlicher fibroblasten durch antimessenger oligonukleotidinhibierung von urokinaserezeptoren-expression | |
CO5040221A1 (es) | Sal fumarato de (r)-5-(metilaminosulfonilmetil)-3-(n-metil- pilrrolidin-2-ilmetil)-1h-indol, composiciones farmaceuticas que contienen la misma y un procedimiento para preparar di- cha sal | |
IL108283A0 (en) | Use of riluzole for promoting restoration following radiation | |
GEP19991605B (en) | Inhibitor, Its Obtaining and Use | |
MD1783G2 (ro) | Metodă de tratament al epilepsiei | |
UA9672A (uk) | Спосіб лікування деструктивних форм гострого панкреатиту |